This study reports the results of a questionnaire survey of female members of the British Epilepsy Association. The women were asked about their epilepsy and its management. A questionnaire was sent to 6000 BEA women members of whom 1855 (31%) replied.
INTRODUCTION
In 1991 the British Epilepsy Association (BEA) carried out a survey of its members, looking particularly at aspects of management of seizure disorders 1 . The aim of this study was to see if there had been many changes since then but also to look specifically at issues relating to the management of women with epilepsy. This article reports the findings with respect to diagnosis and management of seizure disorders in women. A previous article has reviewed women's issues 2 .
MATERIALS AND METHODS
A questionnaire was designed in consultation with Taylor Nelson Sofres Health-care, an independent market research agency. This questionnaire was sent to 6000 BEA women members. Not all these women would have had epilepsy-some would have been carers, others friends etc. Only females with epilepsy aged 16 or above were asked to fill in the questionnaire. This questionnaire was devised following qualitative research with women with epilepsy which was also conducted by Taylor Nelson Sofres Health-care.
RESULTS
Data in the study is based on the 1855 (31%) questionnaires which were returned by the cut-off date for inclusion in the study.
Patient demographics
The ages of the respondents are summarized in Table 1 and their marital and domestic status in Tables 2  and 3 . Eight hundred and eighty (47%) women had had children: 292 (16%) currently had children under the age 10. One thousand and ninety three (59%) of the women were attending a hospital clinic for their epilepsy.
The diagnosis of epilepsy
The majority of women were diagnosed as having epilepsy for more than 10 years previously (55%) whilst nearly a third (31%) were diagnosed more than 20 years previously. Twenty-three percent of respondents were diagnosed within the last 5 years. The average length time since diagnosis was 16 years (Table 4) .
Eighty-five percent of the women claimed that the diagnosis of epilepsy was made by a hospital specialist, most commonly a neurologist (Table 5) . However, one-fifth stated that their GP made the diagnosis. This suggests that although the GP may have made the initial diagnosis, the women were referred on to a specialist for confirmation of the diagnosis. In those cases where a hospital specialist made the diagnosis, 69% of women were diagnosed as having epilepsy by a neurologist, while a further 12% were diagnosed by a paediatrician.
Seizure frequency
Forty percent of women stated that their seizures were rare or that they were seizure free. However, 36% had at least one seizure per month whilst 25% had one or more seizure per week (Table 6) .
Although 36% of women had a seizure at least once a month, only 10% of these women considered their epilepsy to be severe, while 52% felt that their epilepsy was mild and a third considered it to be moderate. Conversely of those women who were seizure, free 2% still considered that they had 'severe' epilepsy whilst another 17% felt that they had moderately severe epilepsy (Table 6 ). 
Seizure type
Many women were unclear as to the type of seizure disorder they had or used the incorrect name (Table 7) . Eleven percent of the women were unaware of the type of seizures they had. Over half the women (54%) claimed that they experienced tonic-clonic or grand mal seizures while a further 20% claimed that they had 'petit mal' and another 10% 'absence' seizures. Twenty percent mentioned experiencing complex partial seizures whilst 3% stated that they had simple partial seizures. The women were asked to describe what happened during one of their seizures. Around half of the women mentioned some effect on the body or convulsions, whilst a similar proportion mentioned some loss of consciousness. Twenty-three percent of respondents mentioned losing consciousness for a short period of time (1-5 minutes).
Management of epilepsy
The majority of the women (89%) stated that they currently took older antiepileptic medications (barbiturates, phenytoin, carbamazepine and sodium valproate), either as monotherapy or in combination with others. Newer antiepileptic drugs (vigabatrin, lamotrigine, gabapentin and topiramate) were prescribed to 30% of women (Table 8 ). In total, three-fifths of the women (59%) were currently taking monotherapy, a third of the women were prescribed two drugs, whilst one-tenth took three or more drugs. The majority of women prescribed newer therapies received these in general as add-on therapy to older antiepileptic drugs-only 6% of women prescribed newer therapies took them as monotherapy.
Looking at individual therapies, 27% of the women were prescribed carbamazapine whilst an additional 20% prescribed Tegretol Retard. Sodium valproate was taken by 25% of women and a further 7% were prescribed Epilim Chrono.
Lamotrigine was the most frequently prescribed of the newer antiepileptic drugs-almost one-fifth (18%) of women were currently taking it. Women prescribed lamotrigine were more likely to take this as monotherapy (24%) than women prescribed one of the other new antiepileptic drugs: gabapentin (10%), vigabatrin (12%) or topiramate (7%).
Phenobarbitone was only taken by women who were diagnosed more than 3 years ago. Phenytoin was less likely to be prescribed to women diagnosed within the last 2 years (only 7% of those diagnosed in the previous 2 years were prescribed phenytoin).
One-third of women indicated that they had not changed their medication since diagnosis, whilst a further third (34%) had been taking their current medication for least 3 years (Table 9 ). 
Effects of epilepsy and medication
The women respondents were asked to describe how their seizure disorder affected them. They attributed a wide variety of effects to their condition (Table 10 ). The most frequently mentioned effects concerned cognition. Over half the women mentioned a variety of cognitive side-effects including tiredness, forgetfulness, confusion and a lack of concentration. The women also associated emotional and cosmetic sideeffects together with effects on the central nervous system. Over half the women (52%) reported that they experienced mood changes which they related to their epilepsy. The main central nervous system side-effects reported were poor coordination, shakiness and dizziness. The women also perceived that they had experienced weight gain or loss, hair growth or loss and changes in their monthly cycle due to epilepsy: each effect was mentioned by over one-third of respondents. The women were also asked which side-effects they felt were due to their antiepileptic medication. Responses indicated that the women ascribed similar effects to both their medication and epilepsy, and indeed a sizeable proportion of respondent were unable to distinguish an effect of their condition from a side-effect from their medication. Again, the most frequently mentioned side-effects were cognitive. Tiredness and forgetfulness were commonly mentioned. The most notable differences concerned cosmetic side-effects. Weight gain due to medication was mentioned by 55% of the total sample compared to 41% attributing it to their epilepsy. Similarly, a greater proportion of women considered hair loss or hair growth to be a sideeffect of their medication. Women were asked to indicate the impact of each side-effect on the lives, using a five-point scale (where 1 = no impact at all and 5 = major impact).
In general, cognitive side-effects were considered to have the greatest impact on the women's lives (Table 11). Conversely, cosmetic side-effects, apart from weight gain, were perceived to have the least impact on daily life. Tiredness had the greatest impact on the women's lives: 70% of the sample considered that the lack of energy had least a moderate impact on their life. This was followed by forgetfulness (61% indicated some impact) and difficult in concentrating (60%). Other cognitive side-effects were considered to have a moderate impact on a woman's life.
Overall, 69% of women were concerned about the long-term effects of their medication, but believed that their medication allowed them to lead a normal life (Table 12) . Thirty-eight percent would have liked better seizure control whilst 32% agreed that they would prefer to change to a medication with fewer sideeffects. However, 49% were reluctant to change their medication. My medication allows me to lead a normal life 3.6 I wish I was able to change my medication to one with fewer side-effects 
Medical care
Women were asked about who they saw regularly about their epilepsy and how often they saw either their GP or their hospital specialist (Tables 13 and 14) . Fifty-nine percent stated that they saw their hospital specialist regularly whilst half the sample (49%) saw their GP regularly. Of the hospital specialists, the women most frequently mentioned seeing a neurologist (50% of the total sample). As would be expected, the women saw their GP more often than they saw their hospital specialist. The women consulted their GP about their epilepsy around an average of three times a year (2.7 times), whilst they visit the hospital specialist around twice a year (1.8 times). Indeed while only one-third (34%) of women saw their specialist twice a year or more, 42% consulted their GP at least twice a year. Seventeen percent of women never see their GP and/or never see a hospital specialist about their epilepsy. On average, women had last seen their GP 5 months previously, and longer time had elapsed since their last consultation with their specialist (8 months previously). Women however would have liked to have seen their GP or hospital specialist about their seizure disorder slightly more often (3.1 times and 2.2 times per year, respectively). Eighty-eight women (5%) with drug resistant epilepsy (1 or more seizure/month) were not or were rarely attending a specialist clinic.
The women were asked about the issues they discussed with their general practitioners and specialist. It was evident from their replies that hospital specialists on the whole, played a more active role in the management of epilepsy than GPs. The women felt that their GP's main task appeared to be to write prescriptions (mentioned by 68%). Only around one-third of women (35%) said that they discussed seizure control or received general lifestyle advice from their GP (31%). Only one-quarter (25%) said that they discussed sideeffects with their GP. However, those women visiting their GP more than once a year were more likely to discuss issues surrounding seizure control (52%), lifestyle (41%) and side-effects (37%) with their GP than the total sample.
In contrast, 56% of the women stated that they discuss seizure control with their specialist, while 39% mentioned side-effects had been discussed. A slightly lower proportion (36%) said they had received general lifestyle advice from their specialist. Again, those women who visited their specialist more than once a year were more likely to have discussed these issues in comparison with the total sample.
The women generally perceived that their GP or specialists were sympathetic to their condition and to their concerns. The women felt that they were able to talk to either the GP or the specialist about medication changes, but a lower proportion (32%) felt that their GP would change their medication if asked. Forty percent of women felt that they knew more about their epilepsy than their GP.
DISCUSSION
Although a large number of women returned the questionnaire, they were not wholly representative of women with epilepsy. The women respondents tended to have had a more severe seizure disorder in that only 40% had well-controlled epilepsy. Community-based audit studies of epilepsy suggest that at least 60% of women with a history of epilepsy were in remission and were seizure free 3, 4 . Fifty-nine percent of the women who returned the questionnaire were currently being followed up in a hospital outpatient clinic. In a recent general practice audit study, 48% of all patients with epilepsy were currently being followed up in a hospital outpatient clinic 3 . Overall 85% of women had had their epilepsy diagnosed by a hospital specialist; the majority had stated that they had seen a neurologist. This correlates well with recent general practice audit data where 79% of people had been seen at a hospital for their epilepsy and 48% had been seen in the previous year 3 .
Despite the higher than average number of women attending hospital outpatient clinics, some women (5% of respondents) with frequent seizures (one or more per month) were rarely or not being seen in secondary or tertiary care. This may have related to the fact that many women with frequent seizures perceived their epilepsy to be of mild or moderate severity.
In common with previous studies 5 , many women were unsure or incorrect as to their seizure type, for example 29% of the women claimed to have absence or petit mal seizures. Absence seizures are uncommon in adulthood, most have ceased by the time the person reaches adulthood. Conversely, complex partial and simple posture seizures, which are probably the most common seizure type in adult life, were reported by 20% and 5% respectively. Even when asked to state what happened during their seizures, many women were unclear-only half mentioned that they lost consciousness.
The majority of women in this survey were receiving older antiepileptic drugs. However the use of the newer antiepileptic agents was increasing-30% were taking one of the four newly licensed drugs. This may in part be due to the fact that many of the women have continuing seizures despite antiepileptic drug therapy and are attending hospital clinics where they were more likely to be prescribed one of the newer antiepileptic drugs. Community-based studies suggest that between 4 and 6% of patients took one of the newer antiepileptic drugs 6 . This was also reflected in the percentage of women on monotherapy (59%) which was lower than in a recent community-based general practice audit study where 71% of 502 patients were on monotherapy 3 .
The high number of women reporting side-effects was even greater than in the previous BEA study. Nearly three-quarters of women felt tired on their medication and in many this was of a severity which they said interfered with their lives. This would suggest that there is a need for new antiepileptic drugs with improved side-effect profiles. However, although the majority of women stated that they would have liked to have taken a more effective medication with fewer side-effects, many also said that they would be reluctant to change their therapy.
A recent study looked at the quality of care and treatment for women with epilepsy. The side-effects of treatment were a common cause of dissatisfaction amongst women with epilepsy and some women felt that these were worse than the seizures themselves 7 .
Most women in this study were happy with the frequency with which they saw their GPs and hospital specialists. However many women felt that their GP's main function was to write prescriptions! Another recent study suggested that GPs should have a broader factual knowledge of epilepsy, especially relating to types of seizures and antiepileptic drug usage. The same study also found that people with epilepsy preferred to have their epilepsy managed in secondary care but was generally satisfied with the services provided by their general practitioner. The few patients who had been referred to an epilepsy clinic felt there had been an improvement in their epilepsy care after referral particularly in respect of information giving 8 .
In our study, a third of the women felt that their GP would change their antiepileptic medication if asked, but a recent study looking at patients views on primary care suggested that this was rarely done. Ninety-two percent of people stated that their doses were rarely or never altered and only 3% had had their antiepileptic drug changed by their GP 8 . This primary care study suggested that overall the majority of people with epilepsy preferred shared care between general practice and the hospital service.
In summary, the majority of women in this study were concerned about their drug treatments, in particular the side-effects. Nearly three quarters of the respondents felt that side-effects, especially tiredness had a major impact on their lives. They were relatively happy about the frequency with which they were seen either by their GP or hospital specialist and felt that they both were sympathetic both to their epilepsy and concerns.
